Bioptimus: Funding, Investors & Team (Sep 2026)
Bioptimus is a developer of a universal AI foundation model that connects biology at all sizes, from molecules to cells, tissues, and entire organisms. The company's technology turns multiscale data into actionable representations, allowing clients to spark breakthrough discoveries and expedite biomedical innovation.
Bioptimus has raised $76.0M across 2 funding rounds on record, the most recent a Series A of $41.0M announced in Jan 2025.
That round is above the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Bioptimus Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Bioptimus Funding Rounds
Bioptimus raised $35.0M in a Seed announced in Feb 2024.
11 months later, a Series A of $41.0M was announced in Jan 2025.
Bioptimus Founders and Leadership Team
Contact details for the Bioptimus team: 1 of 2 have an email address on file.
Start 14-day free trial →Bioptimus Funding Compared to Other Artificial Intelligence Startups
Bioptimus' latest round of $41.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Bioptimus in Artificial Intelligence and Paris
Companies Similar to Bioptimus
Huscarl provides AI-native actuarial advisory and insurance analytics for corporate risk managers and finance…
Macrodata Labs is a technology company that provides data infrastructure for the artificial intelligence and…
Haiku is revolutionizing legal practice by placing artificial intelligence and data at the service of law.…
NotiPark is a fully automated detection and payment solution for parking spaces on public roads using…
Comand AI equips defense forces with unmatched abilities in decision-making and operations.
Reshaping the way businesses understand and leverage creator content —faster, safer, and more effective than…
Rocapine AI-native venture studio focused on developing mobile apps within the digital health and self-care…
Prophesee is the inventor of the world’s most advanced neuromorphic vision systems. Prophesee’s patented…
Kyber is an AI platform that enables teams to build and deploy AI agents that automate workflows across tools…
Alta Ares is a data integration surveillance service provider that utilizes drone imaging.
NP Company is an AI-based software simulation startup that focuses on providing realistic physics simulations.
Dust is a company offering an AI platform that allows businesses to create and implement personalized virtual…
Bioptimus Funding FAQs
What does Bioptimus do?
Bioptimus is a developer of a universal AI foundation model that connects biology at all sizes, from molecules to cells, tissues, and entire organisms. The company's technology turns multiscale data into actionable representations, allowing clients to spark breakthrough discoveries and expedite biomedical innovation.
How much funding has Bioptimus raised?
Bioptimus has raised $76.0M across 2 rounds on record. The most recent is a Series A of $41.0M announced in Jan 2025.
When did Bioptimus last raise funding?
Bioptimus' most recent funding round on record is a Series A of $41.0M, announced in Jan 2025.
Who founded Bioptimus?
FundedIQ lists Eric Durand (Founder), Jean Philippe Vert (Founder) at Bioptimus.
Where is Bioptimus headquartered?
Bioptimus is based in Paris, Ile-De-France, France.
How many employees does Bioptimus have?
Bioptimus is in the 1-10 employee band.
How does Bioptimus' funding compare to other Artificial Intelligence startups?
Bioptimus' latest round of $41.0M is above the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Bioptimus Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bioptimus is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.